Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients

Sponsor
Bnai Zion Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00408759
Collaborator
(none)
10
1
30
10.1

Study Details

Study Description

Brief Summary

xerostomia develops in all patients with head and neck cancer following radiotherapy. it consists one of the main side effects which affects quality of life. currently, there is no standard of care for treating this condition. parasympathomimetic drugs may help but carry significant side effects.

hypnosis may affect autonomic function such as salivation, in healthy people.in this study we will explore the efficacy of hypnosis in improving salivation, in the patient population.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: hypnosis
Phase 2

Detailed Description

10 head and neck cancer patients with xerostomia following radiotherapy will be assessed for severity of xerostomia using questionnares and quantitative salivation tests. patients responsive to citric acid will receive a hypnotic session with specific suggestion for salivation. saliva volume will be assessed pre and post hypnosis. patients will receive a CD with recorded hypnotic session to use freely at home. xerostomia will be assessed using a questionnare one week following hypnosis.

Study Design

Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Phase 2 Study of Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients
Study Start Date :
Nov 1, 2006
Study Completion Date :
Dec 1, 2006

Outcome Measures

Primary Outcome Measures

  1. salivaa volume []

  2. quality of life related to salivation []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • radiotherapy for head and neck cancer

  • xerostomia

Exclusion Criteria:
  • psychiatric illness (present or past)

Contacts and Locations

Locations

Site City State Country Postal Code
1 bnai zion MC Haifa Israel

Sponsors and Collaborators

  • Bnai Zion Medical Center

Investigators

  • Principal Investigator: Elad Schiff, Bnai Zion MC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00408759
Other Study ID Numbers:
  • eschiff
First Posted:
Dec 7, 2006
Last Update Posted:
Dec 7, 2006
Last Verified:
Dec 1, 2006
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 7, 2006